Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 79, Issue 9, Pages (May 2011)
Volume 81, Issue 11, Pages (June 2012)
Volume 78, Issue 11, Pages (December 2010)
Volume 79, Issue 1, Pages (January 2011)
Volume 80, Issue 3, Pages (August 2011)
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 76, Issue 7, Pages (October 2009)
Volume 88, Issue 3, Pages (September 2015)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 84, Issue 3, Pages (September 2013)
Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Jianlin Chen, Martin M. Matzuk, Xin J. Zhou, Christopher Y. Lu 
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Renal denervation prevents long-term sequelae of ischemic renal injury
Volume 76, Issue 3, Pages (August 2009)
Volume 79, Issue 9, Pages (May 2011)
Volume 85, Issue 1, Pages (January 2014)
Volume 82, Issue 8, Pages (October 2012)
Volume 44, Issue 6, Pages (June 2006)
Volume 67, Issue 5, Pages (May 2005)
Volume 74, Issue 7, Pages (October 2008)
Volume 75, Issue 3, Pages (February 2009)
Volume 75, Issue 2, Pages (January 2009)
Volume 87, Issue 2, Pages (February 2015)
Volume 79, Issue 1, Pages (January 2011)
Volume 83, Issue 4, Pages (April 2013)
Volume 86, Issue 3, Pages (September 2014)
Volume 74, Issue 12, Pages (December 2008)
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 69, Issue 12, Pages (June 2006)
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 73, Issue 7, Pages (April 2008)
Volume 80, Issue 12, Pages (December 2011)
Volume 75, Issue 7, Pages (April 2009)
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 66, Issue 6, Pages (December 2004)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 73, Issue 12, Pages (June 2008)
Volume 85, Issue 1, Pages (January 2014)
Volume 73, Issue 2, Pages (January 2008)
Volume 56, Issue 3, Pages (September 1999)
Volume 73, Issue 11, Pages (June 2008)
Volume 63, Issue 5, Pages (May 2003)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 84, Issue 4, Pages (October 2013)
Volume 85, Issue 4, Pages (April 2014)
Volume 85, Issue 4, Pages (April 2014)
Volume 75, Issue 5, Pages (March 2009)
Volume 83, Issue 6, Pages (June 2013)
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 74, Issue 5, Pages (September 2008)
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 59, Issue 6, Pages (June 2001)
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Volume 60, Issue 6, Pages (December 2001)
Volume 75, Issue 5, Pages (March 2009)
Volume 77, Issue 11, Pages (June 2010)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 70, Issue 10, Pages (November 2006)
Volume 84, Issue 1, Pages (July 2013)
Volume 65, Issue 3, Pages (March 2004)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 75, Issue 5, Pages (March 2009)
Volume 85, Issue 1, Pages (January 2014)
Volume 60, Issue 6, Pages (December 2001)
Presentation transcript:

Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney  Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa  Kidney International  Volume 77, Issue 9, Pages 771-780 (May 2010) DOI: 10.1038/ki.2010.12 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Ischemic preconditioning prevents ischemia/reperfusion-induced kidney dysfunction and acute tubular necrosis. C57Bl/6 mice underwent sham surgery or bilateral renal pedicle clamping (IRI) for 24 min on day 0 and were allowed to recover for 7 days. On day 7 mice underwent 28 min IRI. Plasma creatinine was measured periodically to assess renal function (a). At 24 h after the second surgery, kidney sections were fixed and stained with H&E to assess outer medulla acute tubular necrosis in the different treatment groups (b), pictures are representative of at least eight mice per group (c–e). Data are presented as the mean±s.e.m.; *P<0.01 compared to sham/sham control group; #P<0.01 compared to sham/IRI, non-preconditioned group. H&E, hematoxylin and eosin; IRI, ischemia/reperfusion injury. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Ischemic preconditioning inhibits innate leukocyte accumulation after IRI. At 24 h after the second surgery, kidneys were harvested, digested, and stained with neutrophil or macrophage markers and analyzed by flow cytometry as described in the Materials and Methods section. The absolute number of neutrophils (a) and macrophages (b) per gram kidney in each group is represented graphically. Frozen kidney sections were stained with an antibody that recognizes neutrophils and recently emigrated monocytes (7/4) to assess renal accumulation in the different treatment groups, pictures are representative of at least three mice per group (c–e). Data are presented as the mean+s.e.m.; *P<0.01 compared to sham/sham, control mice; #P<0.05 compared to sham/IRI, non-preconditioned group. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Kidney ischemia/reperfusion injury causes kidney Treg cell accumulation. At 3, 7, and 14 days after 24 min IRI (preconditioned) or sham (non-preconditioned) surgery, mouse kidneys and spleen were harvested, digested, and stained for Treg cell markers as described in the Materials and Methods section. The absolute number of Treg cells per gram in preconditioned mice is represented as a percentage of their respective sham control (a). Data are presented as the mean+s.e.m.; *P<0.05, compared to non-preconditioned mice, n=4–8 per group. Frozen sections from sham-operated (b) or 24 min IRI (c, d) kidneys were stained with anti-mouse CD4 (red) and anti-mouse FoxP3 (green) antibodies. Images are from the outer medulla and are representative of at least three animals in each group. Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Kidney ischemia/reperfusion injury causes increased IL-10 production by kidney Treg cells. At 7 days after 24 min IRI (preconditioned) or sham (non-preconditioned) surgery, mouse kidneys were harvested, digested, and stained for Treg cell-surface markers CD4 and CD25, and stained for intracellular IL-10 as described in the Materials and Methods section. The percentage (a) and absolute number (b) of IL-10+ Treg cells per kidney in preconditioned and non-preconditioned mice are represented as the mean+s.e.m.; *P<0.05, compared to non-preconditioned mice, n=6 per group. Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 PC61 administration significantly reduces kidney Treg cells in preconditioned mice. Preconditioned mice were injected with the α-CD25 monoclonal antibody, PC61, or control IgG on day 2 of the IPC protocol (a). On day 7 of reperfusion, kidney Treg cell numbers were determined by flow cytometry (b). Data are presented as the mean+s.e.m.; *P<0.01 vs IRI/IRI-IgG. IPC, ischemic preconditioning; Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Treg cell depletion is associated with inhibition of the anti-inflammatory effects of ischemic preconditioning. Preconditioned mice were injected with the α-CD25 monoclonal antibody, PC61, or control IgG on day 2 of the IPC protocol. On day 8 (24 h after the second surgery), kidney neutrophil (CD45+7-AAD-CD11b+GR-1high; a) and macrophage (CD45+7-AAD-F4/80intCD11b+; b) accumulation were assessed by flow cytometry. Data are presented as the mean+s.e.m.; NS, not significant; Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 7 Treg cell depletion inhibits the kidney functional and histological protection of ischemic preconditioning. Renal function was assessed by measuring plasma creatinine at 24 h after the first surgery (day 1), at the time of the second surgery (day 7), and 24 h after the second surgery (day 8) in non-preconditioned mice treated with IgG or preconditioned mice treated with IgG or PC61 (a). At 24 h after the second surgery, kidney sections were fixed and stained with H&E to assess outer medulla tubular necrosis in preconditioned mice treated with IgG (b) or PC61 (c); pictures are representative of at least four mice per group. Data are presented as the mean+s.e.m.; *P<0.05 compared to sham/IRI-IgG; #P<0.01 compared to IRI/IRI-IgG. IRI, ischemia/reperfusion injury; NS, not significant; Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 8 Adoptive transfer of Treg cells protects the kidney from subsequent ischemia/reperfusion injury. At 18 h before 28 min bilateral renal ischemia, naive C57Bl/6 mice were administered either 1 × 106 CD4+CD25- non-Treg lymphocytes (CD25-), 1 × 105, or 1 × 106 CD4+CD25+ Treg cells by tail vein injection. At 24 h after sham surgery or IRI, renal function was assessed by measuring plasma creatinine levels (a). At 24 h after IRI, kidney sections were fixed and stained with H&E to assess outer medulla tubular necrosis in the different treatment groups (b–e). Data are presented as the mean+s.e.m.; *P<0.05 compared to sham; #P<0.01 compared to CD25--IRI; **P<0.001 compared to CD25--IRI. IRI, ischemia/reperfusion injury; ND, not done; Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 9 Adoptive transfer of Treg cells prevents ischemia/reperfusion-induced inflammation. At 18 h before 28 min bilateral renal ischemia, naive C57Bl/6 mice were administered either 1 × 106 CD4+CD25- non-Treg lymphocytes (CD25-), 1 × 105, or 1 × 106 CD4+CD25+ Treg cells by tail vein injection. At 24 h after sham surgery or IRI, kidney neutrophil (a) and macrophage (b) accumulation was measured by flow cytometry. Frozen kidney sections were stained with an antibody that recognizes neutrophils and recently emigrated monocytes (7/4) to assess renal accumulation in the different treatment groups (c–e). Data are presented as the mean+s.e.m., means with different labels are significantly different from each other, P<0.01. IRI, ischemia/reperfusion injury; ND, not done; Treg, regulatory T. Kidney International 2010 77, 771-780DOI: (10.1038/ki.2010.12) Copyright © 2010 International Society of Nephrology Terms and Conditions